Drawer statement and External Q&As
To be used by AAA Management, PR Teams and Customer-Facing Teams
Posted FYI on “Customer-Facing Employee Resources” internal website
Drawer Statement:
AAA Biologic announced on January 1, 2006, that its subsidiary, AAA, filed an S-1 Registration Statement with the U.S. Securities and Exchange Commission (SEC) for AAA’s initial public offering.
Even with the filing of the S-1, we remain in a “quiet period”. During this quiet period, no one within AAA is at liberty to discuss forward-looking information about AAA (financial outlook, etc.) or specific information about the IPO (timing, valuation, etc.). We can continue to discuss our products and solutions as normal.
As previously announced, we expect to complete the IPO in mid-2006. Further information can be found in the S-1 which is available for public view through the SEC website.
Questions and Answers
Q: How do I find the S-1?
A: Go to the SEC website: www.sec.gov. Click “Search” (in top toolbar). Under “Search Company Filings”, enter company name “AAA”.
Q: How many shares will you offer initially?
A: We expect to determine this later in the process.
Q: How much money do you expect to raise?
A: The exact amount will depend on market conditions and other factors, and will be determined at the time of IPO pricing.
Q: When do you anticipate the registration statement with the SEC to become effective?
A: As previously announced, we expect to complete the IPO in mid-2006.
Q: When will the prospectus be available?
A: [Note that the prospectus is part of the S-1, but that the filing just made is a preliminary filing that will be amended and completed between now and the time that the prospectus becomes available.] Based on our current timing, the prospectus should become available in mid to late May. Our underwriters can provide you with printed versions as they become available. Information on how to obtain a copy will be made available closer to that time.
Q: How do I get a copy of the prospectus?
A: Information on how to obtain a prospectus will be circulated closer to the time that the prospectus will become available.
Q: How long does the quiet period last?
A: The quiet period ends 25 days after completion of the IPO.
Q: Where are AAA headquarters?
A: AAA is incorporated in Singapore, with U.S. headquarters in the San Francisco Bay Area of California. AAA has offices in the U.S., Germany, and China, and Customer Sales, Service & Support locations worldwide
Q: Why is AAA registered in Singapore?
A: For business purposes, AAA has been registered and will have a presence in Singapore as part of our efforts to be located closer to our customer base in that region.
Q: What does “Pte. Ltd.” mean?
A: “Private and Limited” – it is a standard nomenclature for private companies registered in Singapore.
Q: What is the status of your CEO search?
A: Our CEO search is ongoing.
Contacts:
Any inquiries by trade press or industry analysts should be directed immediately to:
AAA Biologic Semiconductor Test PR Manager
BBBaa
+ 888-888-999
Any inquiries by financial analysts or investors should be directed immediately to:
AAA Biologic Investor Relations Director
CCC bb
+1 777-888-999
仅供XXX管理层、公关团队和客户服务团队使用
公布于公司内部网“客户服务员工资源”上仅供参考
内部声明：
XXX生物公司2006年1月1日宣布，其子公司XYZ有限公司已经就其首次公开发行向美国证券交易委员会提交了S-1注册说明书。
虽然报备了S-1说明书，但本公司目前仍然处于“安静期”。在此安静期间， XXX内部任何人员均不得自由讨论有关XYZ的前瞻性信息（财务展望等）或有关IPO的具体信息（如时间和估值等）。本公司可以继续象往常一样讨论公司的产品和解决方案。
正如以前所讨论的，本公司预期将于2006年中期完成首次公开发行（IPO）。其他信息列于S-1表中，通过证券交易委员会的网站供公众查阅。
对外问答
问： 如何获得S-1表?
答： 到证券交易委员会的网站：www.sec.gov，点击“搜索”(在网页顶部)。在“搜索公司备案”项中，输入公司名称“XYZ”。
问： 贵公司首次将发行多少股份?
答： 公司预期将在本项发行工作的后期阶段确定具体要发行的股份的数量。
问： 贵公司预期要通过这次发行募集多少资金？
答： 具体的资金数量将取决于时市场状况和其他因素，并将在首次公开发行的定价阶段予以确定。
问： 预期提交证券交易委员会的注册说明书将于何时生效？
答： 正如以前所公布的，公司预期将于2006年中期完成首次公开发行（IPO）。
问： 什么时间可以提供招股说明书？
答： [注意招股说明书是S-1表的组成部分，但是所报备的资料还仅仅是初步备案资料，该资料从现在开始到招股说明书正式提交前将进行修订和完善。]根据本公司目前的进度安排，招股说明书将于8月中旬到下旬提供。届时，本公司的承销商可以向您提供打印的招股说明书版本。关于如何获得招股说明书文件，将在可提供招股说明书时切近的时间提供。
问： 如何获得招股说明书复制件?
答： 关于如何获得招股说明书文件的信息，将在可提供招股说明书时切近的时间提供。
问： 安静期持续多长时间?
答： 安静期将于完成招股说明书后25天结束。
问： XYZ的总部位于何处？
答： XYZ在新加坡注册成立，美国总部位于加州旧金山海湾地区。XYZ的办事处 遍布美国、德国和中国，其客户销售、服务与支持获得遍布全球各地。
问： XYZ为何在新加坡注册？
答： 为业务目的，XYZ已经在新加坡注册，并将在新加坡建立各种机构，作为本公司在该地区更接近客户之努力的组成部分。
问： “Pte. Ltd.”的含义是什么？
答： “私人有限公司” –是在新加坡注册成立私人公司的标准名称。
问： 贵公司聘请首席执行官的活动进展状况如何？
答： 本公司聘请首席执行官的活动目前正在进行之中。
联系人：
有关商业新闻发布或行业分析的询问，请直接提交：
XXX生物公司业务公关经理
BBBcc
+ 888-888-999
有关财务分析或投资者的询问，请直接提交：
XXX生物公司投资者关系经理
CCCbb
+1 777-888-999
|
